Skip to main content
  • Home
  • Library
  • Read
    • Popular
    • Charts
    • Browse
    • Categories
    • Wikis
    • Glossary
  • Request
  • Activity
  • Leaderboard
  • Help
Our Apps
  • DaoSearch
  • Narratorr
Social
  • Discord
  • Patreon

Recaps

I Can Extract Side Effects
VolumesArcsSummaries

Arc 19Artificial Blood and Nano Pills

Wei Kang and Three Purities expanded Artificial Blood and Nano Pill trials, while Jian Lianyun and Kun City First People's Hospital gained recognition through medical collaboration with Cleveland Clinic. Three Purities’ growth continued, and Wei Kang invested System points in new medical technologies and potential treatments.

  • Director Huang confirmed that the blood sample was Bombay type, and Liu Zhengming’s proposal to use Artificial Blood helped a badly injured patient receive a safe emergency transfusion.
  • Wei Kang launched the electronic journal Life, and the Rare Blood Type Alliance partnered with Three Purities to produce affordable RH-negative blood as artificial blood began replacing the underground rare-blood trade.
  • Wei Kang and Jian Lianyun completed astronaut training, traveled to the Space Station, and returned to Earth after Wei Kang’s spacewalk and their widely watched updates.
  • Director Cui and Xue Kun treated two critically ill patients with Nano Pills, and their recoveries established the first human clinical trial’s success against severe infections.
  • After learning about antibiotic resistance, Wei Kang established plans for an organic farm and research center, while Nano Pills helped Zhu Jun survive a nearly untreatable infection.
  • Director Fang arranged a medical exchange with Cleveland Clinic, and Jian Lianyun successfully operated on a brainstem hemorrhage patient as the hospitals agreed to ongoing cooperation.
  • Wei Kang reviewed Three Purities’ $78.2 billion annual revenue and used System points to obtain an Artificial Heart, other medical devices, and five potential drug treatments.
Chapters 452–478 Vol. 5 Read

Ch. 452First Clinical Application

The Su Province Blood Center confirmed that Three Purities’ Artificial Blood matched Bombay blood type, and clinical trials found no adverse reactions among the volunteers. When a Bombay blood type volunteer suffered a severe accident and faced a shortage of compatible blood, Liu Zhengming and an emergency physician used Artificial Blood to stabilize him, marking its first clinical use.

  • Director Huang confirmed the sample was Bombay blood type and recruited rare-blood and common-blood volunteers for clinical trials.
  • Fifty-six volunteers received small transfusions without adverse reactions, and the trials expanded to partner hospitals.
  • A Bombay blood type volunteer was badly injured in a car accident and needed far more compatible blood than the city could provide.
  • Liu Zhengming proposed using Artificial Blood, and the emergency physician agreed after reviewing the trial report and obtaining the family’s consent.
  • The emergency physician transfused the patient with 200 milliliters of Artificial Blood in 50-milliliter batches, and the patient showed no adverse reactions.
Read chapter

Ch. 453Dinosaur Blood No Longer Rare

After a Bombay Blood Type patient safely received Three Purities' Artificial Blood, news of the treatment spread nationwide and ignited hopes that blood shortages could be overcome. Wei Kang accepted that the breakthrough needed a paper and began considering where to publish it.

  • Liu Zhengming and the emergency doctor confirmed that the patient had no adverse effects after receiving 200 ml of Artificial Blood, but decided to wait for donated blood before surgery.
  • Director Huang told Liu Zhengming that blood shortages were worsening nationwide and resolved to report the development to higher-ups.
  • Online appeals for Bombay blood donors went viral, and volunteers learned that Artificial Blood could serve as a substitute for their rare blood type.
  • Media reports revealed Three Purities' Artificial Blood, prompting widespread public discussion of blood shortages, donation-system problems, and the potential impact of the new product.
  • Wei Kang spoke with Academician Chang Sanwei, who urged him to publish a paper; Wei Kang agreed to have the research materials organized and considered where to submit it.
Read chapter

Ch. 454Luoyang Paper Soars in Price

Wei Kang founded Three Purities’ internal academic journal, Life, to publish company research, with the Artificial Blood paper as its cover article. The first issue spread through domestic and overseas academia, but Professor Duren struggled to understand its Chinese papers and even Google Translate’s English output.

  • Wei Kang rejected expensive, slow core journals and decided Three Purities should publish its own electronic journal, Life, with Artificial Blood as the cover paper.
  • Wei Kang assigned Anmei to assemble the first issue, and she selected ten unpublished papers from the company forum; Huang Qin and Williams were excited to have their work included.
  • A week later, Wei Kang released Life on Three Purities’ website and sent the journal to Chang Sanwei and more than thirty academicians for review.
  • The journal drew intense interest from domestic researchers, companies, public accounts, and students, who studied and discussed its ten papers.
  • Overseas academics struggled to read the Chinese journal, and Professor Duren ordered his assistant to find a biology student to translate it.
  • Professor Duren tried Google Translate, but he could not understand the English translation of the Chinese passage.
Read chapter

Ch. 455Submission Requirements, an Ordinary Person's Rise

Wei Kang announced demanding, free submission standards for Sanqing’s journal, Life, after it gained rapid circulation and SCI indexing. Huang Qin celebrated publishing his first SCI paper, and Williams recognized how Sanqing’s environment had helped an ordinary employee grow into a capable researcher.

  • Anmei reported that Life had surpassed one million downloads and been indexed by SCI, while domestic databases asked to include it.
  • Wei Kang allowed submissions only for innovative Chinese life-science or medical papers with reproducible experiments and warned that misconduct would bring rejection and blacklisting.
  • Researchers debated the strict requirements, but many welcomed the chance to publish without fees.
  • Huang Qin celebrated finding his paper in Life, and Williams reassured him that his research ability had grown through his work at Sanqing.
  • Williams reflected on Huang Qin’s progress and recognized that Sanqing’s resources and guidance could help ordinary people develop their potential.
  • Huang Qin said his first SCI paper might be the brightest moment of his life, and Williams told him it was only the beginning.
Read chapter

Ch. 456Rare Blood Type Alliance

Xie Tianyin coordinated rare-blood donations in Sea City, but a young girl died before her donor arrived and a two-year-old boy died despite receiving blood. News of Three Purities’ Artificial Blood inspired the alliance to petition for RH-negative supplies, and Xie agreed to contact the company and blood center.

  • Xie Tianyin verified new RH-negative volunteers and recruited a donor for a seven-year-old girl with Aplastic Anemia, but she died just as the donor arrived.
  • Xie refused to recruit eight donors for a two-year-old boy who needed 3,000 milliliters of RH-negative O blood because the surgery had a very low chance of success.
  • The donor, The Boat Reaches the Bridge and Sinks Naturally, blamed himself for arriving too late and left the group after the girl’s death.
  • Xie learned that the boy also died after his parents found blood through other means, and he felt relieved that alliance volunteers had not been used for the operation.
  • After members discussed Three Purities’ Artificial Blood, Xie agreed to contact the company and blood center about producing RH-negative supplies.
Read chapter

Ch. 457A Win-Win Partnership

Wei Kang agreed to work with the Rare Blood Type Alliance to develop RH-negative Artificial Blood and strengthen blood supplies, hoping to end illegal blood trading. The chapter ended with Ding Mian collecting stem cells from three Alliance representatives and estimating that the first RH-negative blood could be ready within eighteen days.

  • Wei Kang considered the Rare Blood Type Alliance's proposal after learning its members would volunteer for clinical trials and provide hematopoietic stem cells.
  • Xie Tianyin, Chang Hao, and Lin Xi explained their donation work and warned that high prices for RH-negative blood were drawing volunteers into the underground market.
  • Wei Kang agreed to prioritize rare blood types, provide RH-negative blood reserves at ordinary blood prices, and collaborate with the Alliance and Director Huang.
  • Wei Kang explained that RH-negative blood could be produced from the representatives' stem cells without regard to ABO type, and Ding Mian led them to the laboratory.
  • Ding Mian collected stem cells from the three representatives and said Three Purities could deliver RH-negative blood to the blood station within eighteen days.
Read chapter

Ch. 458The Blood Dealer's End

Zuo Ying, an Rh-negative mother, avoided blood dealers and received Artificial Blood during a difficult delivery, giving birth safely to a daughter. As hospitals began using Artificial Blood for patients, the fat blood middleman lost his customers and realized his business was collapsing.

  • Zuo Ying and her husband found a hospital willing to admit her and prepare Rh-negative blood before delivery.
  • A fat middleman offered Zuo Ying fifty thousand yuan for 400 milliliters of her rare blood, but she refused to sell it.
  • When Zuo Ying suffered bleeding during delivery, the doctor used Artificial Blood for her surgery, and she safely gave birth to a daughter who also had Rh-negative blood.
  • A middle-aged man canceled his order for blood from the fat middleman after learning Three Purities could provide Artificial Blood for his father's surgery.
  • The fat middleman received calls from customers canceling their blood orders and demanding refunds, then collapsed as he realized his business was finished.
Read chapter

Ch. 460Dual-Track Approach

Xie Tianyin explained that artificial blood and free blood donation would operate in parallel while artificial blood remained costly and scarce, as Ding Mian’s team worked to expand production. The rocket launch date was set, and Wei Kang and Jian Lianyun prepared for their final training before going to the Space Station.

  • Xie Tianyin told the Rare Blood Type Alliance that free blood donation would continue alongside artificial blood to meet demand and keep blood affordable.
  • Ding Mian inspected the artificial-blood production line and instructed workers on cultivating stem cells and standardizing procedures for future expansion.
  • Ding Mian explained the risks of paid blood donation and argued that voluntary donation and artificial blood should operate in parallel.
  • Wei Kang learned that the rocket launch was set for December 30 and that he and Jian Lianyun would spend three days at the Space Station.
  • Wei Kang and Jian Lianyun were scheduled to begin their final fourteen-day intensive astronaut training on December 15.
Read chapter

Ch. 461Space Honeymoon Trip

Wei Kang and Jian Lianyun completed their astronaut training and traveled to the launch site for their space honeymoon. After the rocket launched, Wei Kang stepped out of the cabin and entered the Space Station.

  • Wei Kang announced the launch date for his space honeymoon, and news of his trip sparked widespread discussion online.
  • At the Aerospace Training Center, Su Yang showed Wei Kang and Jian Lianyun third-generation Feitian extravehicular spacesuits and gave them two suits as souvenirs.
  • Wei Kang and Jian Lianyun passed their final training assessment with high scores and continued intensive preparation.
  • At Aerospace City, Fang Heng showed them the rocket and explained the assembly and launch schedule as Wei Kang watched it take shape.
  • Wei Kang and Jian Lianyun boarded the rocket, which launched with them secured inside.
  • Six and a half hours later, Wei Kang stepped from the rocket cabin into the Space Station.
Read chapter

Ch. 462Returning with Dreams Fulfilled

Wei Kang and Jian Lianyun fulfilled their dream of visiting the Space Station, sharing photos and videos that excited the public before returning to Earth. As they began rehabilitation after the trip, Jian Lianyun received alarming news about a patient.

  • Wei Kang took photos during his first moments in space, completed a spacewalk with the Five-Starred Red Flag, and called Sun Chengren and his in-laws.
  • Wei Kang posted photos from the Space Station, and he and Jian Lianyun shared videos of their daily life that drew widespread attention online.
  • Jian Lianyun gave up her planned spacewalk because her upper-body strength and training were insufficient for the demanding spacesuit.
  • Wei Kang and Jian Lianyun left the Space Station, returned to Earth, and traveled to an aerospace rehabilitation center in the Capital City.
  • Wei Kang read a notice announcing a commercial astronaut training program as Jian Lianyun reacted to news that a patient had acquired an infection in the hospital.
Read chapter

Ch. 463A Sudden Hospital-acquired Infection

Jian Lianyun learned that a hospital-acquired MRSA outbreak had infected five ICU patients, including her elderly postoperative patient, and Wei Kang proposed using Three Purities’ Nano Pill. As the ICU struggled to treat the two critically ill patients, Director Cui agreed to revise the treatment plan and bring in the Nano Pills for clinical testing.

  • Jian Lianyun told Wei Kang that five ICU patients had contracted MRSA and that her elderly patient was in grave condition.
  • Wei Kang explained that Three Purities’ Nano Pill had shown promising results against bacterial infections in animal trials and offered to prepare it for the hospital.
  • Director Cui reviewed the outbreak, as Xiao Fang and two other young patients recovered while two frail patients remained seriously ill despite antibiotics.
  • Director Cui considered stronger antibiotics after Vancomycin and Linezolid proved insufficient for the two patients.
  • Director Cui learned that Three Purities’ Nano Pill was entering human clinical trials and agreed to create a new treatment plan and request the pills.
Read chapter

Ch. 464Nano Pill

Xue Kun brought Three Purities' Nano Pill to Director Cui's hospital to treat a patient with a severe lung infection, explaining how the algae-powered nanorobots carried and released antibiotics. After the patient's family signed the clinical trial consent form, Xue Kun and Director Cui prepared to administer the treatment.

  • Director Cui welcomed Xue Kun from Three Purities, who delivered a refrigerated Nano Pill containing Tykoralin for the patient.
  • Director Cui arranged for the patient's family to sign a clinical trial consent form before the new treatment was administered.
  • Xue Kun explained how the algae-powered nanorobots could move through lung fluid, deliver antibiotics to an infection, and degrade after treatment.
  • Director Cui learned that Xue Kun was a physicist and listened as he described the limits and possible future generations of nanorobots.
  • A nurse told Director Cui that the family had signed the papers, and Xue Kun followed him toward the ICU with the Nano Pill.
Read chapter

Ch. 465The Superbug Has Been Brought Under Control

Xue Kun and Director Cui treated two critically ill ICU patients with Nano Pills, and their fevers and inflammatory markers quickly fell. The Superbug infection was under control, though the patients still required monitoring and continued treatment.

  • Director Cui and Xue Kun administered Nano Pill medication directly into the chest cavities of the two patients with severe lung infections.
  • Xue Kun explained that the Nano Pill would release antibiotics near the lung lesions, and Director Cui arranged to monitor the patients for a day and continue treatment.
  • At dinner, Xue Kun told Director Cui about his research background and his work at Three Purities.
  • Nurse Li called to report that both patients' fevers had dropped to 37.8 degrees, so Director Cui and Xue Kun hurried back to the ICU.
  • Director Cui checked the patients' blood tests and found that their White Blood Cell counts, Neutrophil Percentages, and C-reactive Protein levels had fallen, showing that the Superbug was under control.
Read chapter

Ch. 466Infection Control Was Saved

Xue Kun’s Nano Pills cured two ICU patients infected with MRSA, saving Director Cui from the consequences of a hospital-acquired infection and completing the first human clinical trial. News of the treatment spread to other hospitals, accelerating interest in Nano Pills as a way to fight Superbugs and reduce antibiotic use.

  • The two patients woke up, cleared their airways, and showed improved lung scans and inflammation markers after Nano Pill injections.
  • Director Cui thanked Xue Kun for the treatment, while an Infection Control Department doctor blamed ICU hygiene practices and warned that the patients’ families might seek compensation.
  • Director Cui learned that Bed Two’s patient had been Dr. Jian’s case, but the families accepted waived treatment fees and did not pursue the matter after the patients recovered.
  • The patients came off ventilators and transferred to regular wards, concluding the first Human Clinical Trial of Nano Pills and preserving Director Cui’s position.
  • News of Nano Pills’ success against MRSA spread among major hospitals, drawing interest from hospitals and patients with antibiotic-resistant infections.
Read chapter

Ch. 467Drug-Resistant Baby, Huang Qin's Dream

Director Song explained how Sanqing’s Nano Pill saved a premature infant with antibiotic-resistant infections and warned that antibiotic overuse in livestock was contributing to drug resistance. At the company dormitory, Xue Shen encouraged Huang Qin to pursue a PhD, and Huang Qin began imagining a future as an academician.

  • Director Song recalled how Sanqing’s Nano Pill delivered vancomycin and cured a premature infant resistant to seven antibiotics.
  • Director Song warned a colleague that antibiotic residues in meat and eggs could pass drug resistance to newborns, while new antibiotics could not be developed quickly enough.
  • Xue Shen finished the Nano Pill Phase II clinical trial report and planned to report it to President Wei before starting Phase III.
  • Xue Shen shared his difficult PhD experience with Huang Qin over barbecue and praised Huang Qin’s research work.
  • Xue Shen urged Huang Qin to consider pursuing a PhD to advance his career, and Huang Qin asked about an integrated program near the company.
  • Huang Qin grew excited about earning a doctorate and imagined that his research ambitions might someday make him an academician.
Read chapter

Ch. 468Responding to the Antibiotic Crisis: The Real Technology and Ruthless Tactics

After reviewing the Nano Pill trial report, Wei Kang became alarmed by antibiotic resistance linked to livestock and decided Sanqing should produce its own organic meat. He arranged to acquire disease-resistant pigs and chickens and build a farm and research center for internal supply.

  • Wei Kang read the Nano Pill trial report and learned how widespread drug-resistant infections, including among babies, had become.
  • Worried about antibiotic use in livestock and his family's future health, Wei Kang decided to establish a farm raising disease-resistant animals without growth-promoting antibiotics.
  • Huang Qin told Wei Kang that disease-resistant pigs were already available and that researchers had developed a promising disease-resistant White Feather Chicken.
  • Wei Kang asked Huang Qin to contact New Hope and the Academy of Agricultural Sciences to purchase breeding stock, then told Sun Chengren to find a suitable site for an organic farm and research center.
  • Sun Chengren agreed to oversee the project, and Wei Kang said Sanqing would use genetic research to produce reliable, pollution-free food for its employees and families.
Read chapter

Ch. 469King of Strong Mouth at the End of His Rope

After years of building a hopeful life despite paralysis, Zhu Jun fell critically ill with a severe, highly drug-resistant Pseudomonas aeruginosa infection. As his condition worsened and doctors struggled to find a safe treatment, Zhu Ming decided to ask Zhu Jun’s online fans to help locate experts.

  • Zhu Jun recalled his accident, years of despair, and eventual recovery of purpose through gaming and online content creation as doctors rushed him into emergency care.
  • Dr. Zhao admitted Zhu Jun to the ICU after he lost consciousness, then suspected a Pseudomonas aeruginosa infection that had spread from his urinary tract to his lungs.
  • Laboratory tests showed the infection resisted nearly every antibiotic, leaving Polymyxin as a possible option despite its serious kidney risks.
  • A nurse told Dr. Zhao that Zhu Jun was already showing signs of kidney failure, prompting him to seek an expert consultation.
  • Dr. Zhao explained Zhu Jun’s grave condition to Zhu Ming, who decided to use his brother’s online following to find medical experts who could help.
Read chapter

Ch. 470NDM-1 Resistance Gene, Combination Therapy

Zhu Jun’s brother appealed online for expert help as doctors discovered that a drug-resistant Pseudomonas aeruginosa infection had left Zhu Jun critically ill. Xue Shen brought Three Purities’ Nano Pills to the hospital, and the doctors began combination treatment with Polymyxin and Tigecycline.

  • Zhu Ming posted a video explaining Zhu Jun’s critical condition and asking specialists to come to Zhejiang Provincial People's Hospital.
  • Doctors at the hospital found that Zhu Jun’s Pseudomonas aeruginosa carried the NDM-1 resistance gene and discussed using Polymyxin with Tigecycline.
  • The ICU director proposed using Three Purities’ Nano Pills to deliver smaller antibiotic doses while reducing liver and kidney toxicity.
  • Xue Shen arrived with Nano Pills and showed Dr. Zhao how to load them with Polymyxin and Tigecycline at the hospital.
  • The ICU director injected both Nano Pill solutions into Zhu Jun’s veins as the department heads watched.
Read chapter

Ch. 471Between Life and Death, There Is Great Hope

After Sanqing Group’s Nano Pills helped save Zhu Jun from a drug-resistant infection, he regained consciousness and found hope that future technology might treat his high paraplegia. Meanwhile, Cleveland Clinic director Dr. Harrison arranged for a team of experts to travel to China and observe Nano Pill treatments.

  • Zhu Ming posted a video announcing that Zhu Jun had regained consciousness and crediting Sanqing Group’s Nano Pills and antibiotic treatment with saving him.
  • Netizens discussed a report explaining how Nano Pills deliver antibiotics to infections, and the technology became widely popular.
  • Zhu Jun learned how close he had come to death, then went outside in his wheelchair and resolved to live for the eight years remaining on his original prognosis while hoping for a treatment.
  • Dr. Harrison presented a Nano Pill clinical trial paper and a report about Zhu Jun’s case to Cleveland Clinic experts, who praised the treatment’s potential.
  • Dr. Harrison told the experts that they would travel to China in two days to observe Phase III Nano Pill trials in Kun City.
Read chapter

Ch. 472Cleveland Training Journey (Part 1)

Director Fang welcomed Dr. Harrison and twelve department heads from Cleveland to Kun City First People's Hospital, where they negotiated an exchange that let the visitors join Three Purities' Clinical Trials in return for teaching and clinical work. The visitors began learning about the hospital’s advanced treatments, and Dr. Roman answered Dr. Jian’s question about brainstem hemorrhage surgery.

  • Director Fang greeted Dr. Harrison and the Cleveland delegation at the hospital, then led them on a tour of its outpatient, emergency, ICU, and surgical facilities.
  • Director Fang privately planned to delay the visitors’ access to the Clinical Trials until Phase III and make the exchange benefit the hospital’s staff.
  • At a meeting, Director Fang offered the delegation access to ongoing Clinical Trials in exchange for daily outpatient consultations, a demonstration surgery, and a lecture.
  • Dr. Harrison agreed to the conditions, and Director Fang arranged for the visitors to begin learning about Artificial Blood, Nano Pills, and capsule gastrointestinal endoscopy that afternoon.
  • Dr. Jian asked Dr. Roman about neuroendoscopic surgery for brainstem hemorrhage, and Dr. Roman described precise localization and careful hematoma removal as key steps.
Read chapter

Ch. 473Cleveland Training Tour (Part 2)

Jian Lianyun impressed the Cleveland Clinic visitors with her neurosurgical experience, and they were amazed by Kun City First People's Hospital's capabilities and Nano Pills. Meanwhile, Grandpa Zhang and his son accepted a bypass operation after a consultation with Director Gao and Dr. Charlie, then left proud to have secured treatment from a renowned foreign surgeon.

  • Jian Lianyun told Dr. Roman that she had already performed seven or eight of the challenging surgeries, astonishing him and the other Cleveland visitors.
  • Director Fang and the hospital staff exchanged medical knowledge with the visitors, who admired the hospital's clinical strength and watched Nano Pills being loaded with drug molecules.
  • Grandpa Zhang and his son learned that Cleveland Clinic experts were consulting at the hospital and met Director Gao and Dr. Charlie for a cardiac assessment.
  • Director Gao and Dr. Charlie recommended bypass surgery for Grandpa Zhang's severe coronary disease, and his son persuaded him to accept the operation despite its cost.
  • Grandpa Zhang and his son saw Dr. Charlie's résumé and proudly told other patients that they had arranged for the foreign expert to help perform the surgery.
Read chapter

Ch. 474Utterly Convinced

Jian Lianyun persuaded a hesitant family to consent to emergency surgery for a massive brainstem hemorrhage, then led a five-and-a-half-hour operation that saved the patient. Dr. Roman revealed that Jian had performed the surgery herself, and the family apologized and thanked her.

  • Jian Lianyun and Dr. Roman assessed the unconscious patient’s eleven-milliliter brainstem hemorrhage and determined that emergency surgery was necessary.
  • The patient’s sister-in-law opposed the operation and wanted to wait for an expert from Sea City, but Jian Lianyun gained the family’s consent by invoking Dr. Roman’s expertise.
  • Jian Lianyun led the operation and, when suction could not remove the clotted hematoma, followed advice to extract it bit by bit with forceps.
  • After the successful surgery, Dr. Roman told the family that Jian Lianyun had performed the operation and praised her skill.
  • The family thanked Jian Lianyun, and the patient’s sister-in-law apologized for doubting her.
Read chapter

Ch. 475Deep Cooperation, Returning Fully Loaded

At Kun City First People's Hospital, Cleveland Clinic experts praised the Nano Pill and Three Purities's Artificial Blood while discussing antibiotic resistance and medical advances. Dr. Harrison secured long-term cooperation with Director Fang, and the foreign experts left after helping raise the hospital's profile and attract patients.

  • A patient with multidrug-resistant Acinetobacter baumannii recovered after treatment with antibiotics carried by the Nano Pill and moved from the ICU to a regular ward.
  • Dr. Hank explained that antibiotic resistance was worsening worldwide, while Dr. Harrison and Dr. Roman argued that continued scientific progress could still bring victories against bacteria.
  • The doctors praised Three Purities's Artificial Blood and discussed its potential to lead to artificial organs, while Dr. Roman commended Dr. Jian's surgical skill.
  • Dr. Harrison revealed that Dr. Jian was Mr. Wei's wife and presented a cooperation agreement with Director Fang to send two groups of Cleveland Clinic doctors to Kun City each year.
  • Dr. Roman praised Chinese hospitals for exposing doctors to complex cases and broader training, and the experts discussed establishing a lasting exchange between the hospitals.
  • The Cleveland Clinic experts departed after the cooperation drew publicity, patients, and funding for Kun City First People's Hospital, and Academician Fang hosted a farewell banquet and saw them onto their plane.
Read chapter

Ch. 477Second Place, Eyeing First

Wei Kang reviewed Three Purities' financial results and celebrated that the company had become the pharmaceutical industry's second-largest by revenue, while planning to overtake Johnson & Johnson. He remained confident that Three Purities' expanding drug and medical equipment businesses would sustain its growth.

  • Wei Kang reviewed Three Purities' annual report, which showed revenue reaching $78.2 billion, driven especially by medical equipment.
  • Wei Kang saw HIV drug sales growth disappear and expected the business to decline as patients were cured, but trusted Three Purities' other medicines and research pipeline to keep the company growing.
  • Wei Kang compared quarterly reports and laughed that Gilead's anti-AIDS market was shrinking even faster than Three Purities'.
  • Wei Kang celebrated that Three Purities' total revenue had surpassed Pfizer's and ranked second in the pharmaceutical industry, behind Johnson & Johnson.
  • Wei Kang predicted that Three Purities would strengthen its medical equipment business and overtake Johnson & Johnson for first place.
Read chapter

Ch. 478Points Exchange, Extraction Once Again

Wei Kang spent his accumulated system points on an Artificial Heart, an Ultrasonic Scalpel, a Bionic Blood Vessel, and a Bionic Painless Syringe. He then extracted five useful side effects from discarded prescriptions, leaving himself with new drug-development prospects.

  • Wei Kang checked the System Mall and confirmed that he had 13,520,062 points.
  • Wei Kang exchanged ten million points for an Artificial Heart after weighing it against other artificial organs.
  • Wei Kang spent more points on an Ultrasonic Scalpel, a Bionic Blood Vessel, and a Bionic Painless Syringe.
  • Wei Kang searched discarded prescriptions and selected five side effects that could be repurposed into treatments.
  • Wei Kang extracted the five side effects for potential drugs targeting Chronic Nephritis, oxidative damage, asthma, high blood sugar, and inflammation.
Read chapter
Arc 19 of 27
AboutStatsAPIChangelogStatusContactPrivacyTermsDMCA
© 2026 RandomTranslator·v3.26·RSS